Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Direct Oral Anticoagulant Versus Low Molecular Weight Heparin for the Treatment of Cancer-Associated Thromboembolism: 2021 Updated Meta-Analysis of Randomized Controlled Trials

Corinne Frere, Dominique Farge, Deborah Schrag, Pedro H. Prata, Jean M. Connors

Blood (2021) 138 (Supplement 1): 668.

https://doi.org/10.1182/blood-2021-150696

Published: 2021

Journal Articles

Incidence and Risk Factors for Central Venous Catheter-Related Venous Thromboembolism in Breast Cancer Patients Under Neoadjuvant Chemotherapy: the Caveccas (Catheter Veineux Central et Cancer du Sein) Study

Philippe Debourdeau, MD, Marc Espié, MD, Sylvie Chevret, MD PhD, Joseph Gligorov, MD PhD, Antoine Elias, MD PhD, Pierre Francois Dupré, MD, Joel Le Long, MD, Sandrine Lavau-Denes, MD, Marie-Antoinette Sevestre, MD PhD, Laurent Bastit, MD, Issa Kalidi, MD, Corinne Frere, MD PhD, Dominique Farge, MD PhD

Blood (2016) 128 (22): 2607.

https://doi.org/10.1182/blood.V128.22.2607.2607

Published: 2016

Journal Articles

A meta-analysis of genome-wide association studies identifies ORM1 as a novel gene controlling thrombin generation potential

Blood (2014) 123 (5): 777–785.

https://doi.org/10.1182/blood-2013-10-529628

Published: 2014

Includes: Supplemental data

Journal Articles

Tissue factor–positive neutrophils bind to injured endothelial wall and initiate thrombus formation

Roxane Darbousset, Grace M. Thomas, Soraya Mezouar, Corinne Frère, Rénaté Bonier, Nigel Mackman, Thomas Renné, Françoise Dignat-George, Christophe Dubois, Laurence Panicot-Dubois

Blood (2012) 120 (10): 2133–2143.

https://doi.org/10.1182/blood-2012-06-437772

Published: 2012

Includes: Multimedia, Supplemental data

Journal Articles

Thr325Ile polymorphism of the TAFI gene does not influence the risk of myocardial infarction

Pierre E. Morange, Mireille Henry, Corinne Frere, Irène Juhan-Vague

Blood (2002) 99 (5): 1878.

https://doi.org/10.1182/blood.V99.5.1878a

Published: 2002

NARROW

Direct Oral Anticoagulant Versus Low Molecular Weight Heparin for the Treatment of Cancer-Associated Thromboembolism: 2021 Updated Meta-Analysis of Randomized Controlled Trials

Incidence and Risk Factors for Central Venous Catheter-Related Venous Thromboembolism in Breast Cancer Patients Under Neoadjuvant Chemotherapy: the Caveccas (Catheter Veineux Central et Cancer du Sein) Study

A meta-analysis of genome-wide association studies identifies ORM1 as a novel gene controlling thrombin generation potential

Tissue factor–positive neutrophils bind to injured endothelial wall and initiate thrombus formation

Thr325Ile polymorphism of the TAFI gene does not influence the risk of myocardial infarction

Email alerts

ASH Publications

American Society of Hematology

Direct Oral Anticoagulant Versus Low Molecular Weight Heparin for the Treatment of Cancer-Associated Thromboembolism: 2021 Updated Meta-Analysis of Randomized Controlled Trials

Incidence and Risk Factors for Central Venous Catheter-Related Venous Thromboembolism in Breast Cancer Patients Under Neoadjuvant Chemotherapy: the Caveccas (Catheter Veineux Central et Cancer du Sein) Study

A meta-analysis of genome-wide association studies identifies ORM1 as a novel gene controlling thrombin generation potential

Tissue factor–positive neutrophils bind to injured endothelial wall and initiate thrombus formation

Thr325Ile polymorphism of the TAFI gene does not influence the risk of myocardial infarction

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only